Clinuvel Pharmaceuticals Limited (ASX:CUV)
Australia · Delayed Price · Currency is AUD 9.44
+0.07 (0.75%)
Aug 7, 2026, 4:10 PM AEST
Clinuvel Pharmaceuticals Market Cap
Clinuvel Pharmaceuticals has a market cap or net worth of 476.04 million as of August 7, 2026. Its market cap has decreased by -22.66% in one year.
Market Cap
476.04M
Enterprise Value
243.36M
Revenue
96.30M
Ranking
n/a
PE Ratio
14.67
Stock Price
9.44
ChartMarket Cap Chart
Since February 13, 2001, Clinuvel Pharmaceuticals's market cap has increased from 5.23M to 476.04M, an increase of 9,009.64%. That is a compound annual growth rate of 19.36%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2026 | 476.04M | -23.89% |
| Dec 31, 2025 | 625.50M | 3.84% |
| Dec 31, 2024 | 602.36M | -24.90% |
| Dec 29, 2023 | 802.04M | -25.09% |
| Dec 30, 2022 | 1.07B | -20.36% |
| Dec 31, 2021 | 1.34B | 21.91% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Clarity Pharmaceuticals | 999.86M |
| Tetratherix | 400.04M |
| Racura Oncology | 396.99M |
| Starpharma Holdings | 336.92M |
| BLS Pharmaceuticals | 202.38M |
| Orthocell | 198.75M |
| Dimerix | 174.12M |
| Nyrada | 167.89M |